Filter by Product area
Filter by Country
Brand
Generic
Country
A FUSIDIQUE
BETAMETHASONE
Iraq
A FUSIDIQUE 2
BETAMETHASONE
Libya
A FUSIDIQUE 3
BETAMETHASONE
Tunisia
ABUFENE DELICATE
SODIUM HYALURONATE
Ukraine
ABUFENE
BETA ALANINE
Armenia
ABUFENE
BETA ALANINE
Belarus
ABUFENE
BETA ALANINE
Georgia
ABUFENE
BETA ALANINE
Kazakhstan
ABUFENE
BETA ALANINE
Luxembourg
ABUFENE
BETA ALANINE
Mongolia
ABUFENE
BETA ALANINE
Russian Federation
ABUFENE
BETA ALANINE
Tunisia
ABUFENE
BETA ALANINE
Ukraine
ABUFENE
BETA ALANINE
Uzbekistan
ACEQUIDE
QUINAPRIL
Italy
ACEQUIN
QUINAPRIL
Italy
ACICLOVIR
ACICLOVIR
Libya
ACICLOVIR
ACICLOVIR
Tunisia
ACIDO ALENDRONICO
SODIUM ALENDRONATE TRIHYDRATE
Portugal
ACIRYL
PREGABALIN
Iraq
ACIRYL
PREGABALIN
Tunisia
ACYCLOVIR
ACICLOVIR
Italy
ACYLPYRIN
ACETYLSALICYLIC ACID
Czech Republic
ACYLPYRIN
ACETYLSALICYLIC ACID
Slovakia
ADULAX
GLYCEROL
Georgia
ADULAX
GLYCEROL
Kazakhstan
ADULAX
GLYCEROL
Spain
AETHOXYSKLEROL
POLIDOCANOL
Switzerland
AIRCORT
BUDESONIDE
Italy
AKNETRENT
ISOTRETINOIN
Turkey
ALERGOSONE
BETAMETHASONE
Libya
ALERGOSONE
BETAMETHASONE
Tunisia
ALEZINE
LEVOCETIRIZINE
Tunisia
ALFAVIT
VITAMINS
Belarus
ALFAVIT
VITAMINS
Kazakhstan
ALFAVIT
VITAMINS
Kyrgyzstan
ALFAVIT
VITAMINS
Mongolia
ALFAVIT
VITAMINS
Russian Federation
ALFAVIT
VITAMINS
Tajikistan
ALFAVIT
VITAMINS
Ukraine
ALFAVIT
VITAMINS
Uzbekistan
ALGESAL
DIETHYLAMINE SALICYLATE
Turkey
ALGESTIN
DIETHYLAMINE SALICYLATE
Georgia
ALGIMATE
LYSINE CLONIXATE
Portugal
ALIPZA
PITAVASTATIN
Portugal
ALIPZA
PITAVASTATIN
Turkey
ALJIL
PARACETAMOL
Libya
ALJIL
PARACETAMOL
Turkey
ALOBABY
HYALURONIC ACID
Portugal
ALOCLAIR
HYALURONIC ACID
Portugal
ALOVEX
ACICLOVIR
Italy
ALPROSTAR
ALPROSTADIL
Italy
AMBENE
SODIUM PHENYLBUTAZONE
Germany
AMLODIPINA JABA
AMLODIPINE
Portugal
AMUCHINA
SODIUM HYPOCHLORITE
Tunisia
AMUSTIL
TRICLOSAN
Tunisia
ANTISPASMINA
PAPAVERINE HYDROCHLORIDE
Italy
APYROSIS
SODIUM ALGINATE
Libya
APYROSIS
SODIUM ALGINATE
Tunisia
ARGININA
ARGININE HYDROCHLORIDE
Italy
ARGINO B
ARGININE
Libya
ARGINO B
ARGININE
Tunisia
AROE
GALATTOMANNAN
Italy
ASEPSIL
CHLORHEXIDINE
Tunisia
ASTAIR
#N/A
Tunisia
ASTERANE
ARCTIUM LAPPA
Kenya
ASTERANE
ARCTIUM LAPPA
Tunisia
ATOVER
LERCANIDIPINE HYDROCHLORIDE
Italy
AURIPAX
PHENAZONE
Senegal
AURIPAX
PHENAZONE
Tunisia
AVILUT
LUTHEIN
Czech Republic
AVILUT
LUTHEIN
Slovakia
AVODART
DUTASTERIDE
Austria
AVODART
DUTASTERIDE
Belgium
AVODART
DUTASTERIDE
Czech Republic
AVODART
DUTASTERIDE
Finland
AVODART (GSK)
DUTASTERIDE
Germany
AVODART
DUTASTERIDE
Greece
AVODART
DUTASTERIDE
Ireland
AVODART
DUTASTERIDE
Italy
AVODART
DUTASTERIDE
Luxembourg
AVODART
DUTASTERIDE
Poland
AVODART
DUTASTERIDE
Portugal
AVODART
DUTASTERIDE
Spain
AVODART
DUTASTERIDE
Sweden
AVODART
DUTASTERIDE
Switzerland
AVODART
DUTASTERIDE
United Kingdom
AXEN
KETOPROFEN
Libya
AXEN
KETOPROFEN
Tunisia
AZITROMICINA 3Z
AZITHROMYCIN
Portugal
B-12
VITAMIN B12
Italy
BASDENE
BENZYL 6 THIO 2 URACILE (BTU)
Tunisia
BELOC MITE
METOPROLOL TARTRATE
Austria
BELOC ZOC
METOPROLOL SUCCINATE
Estonia
BELOC
METOPROLOL TARTRATE
Austria
BELOC
METOPROLOL TARTRATE
Germany
BELOC
METOPROLOL TARTRATE
Switzerland
BELOC-ZOK
METOPROLOL SUCCINATE
Germany
BELOC-ZOK
METOPROLOL SUCCINATE
Switzerland
BELOKEN
METOPROLOL SUCCINATE
Spain
BELYI UGOL
CHARCOAL
Russian Federation
BETACAROTENE
BETA CAROTENE
Italy
BETADORM
DIPHENHYDRAMINE HYDROCHLORIDE
Germany
BETALOC ZOK
METOPROLOL SUCCINATE
Bulgaria
BETALOC ZOK
METOPROLOL SUCCINATE
Estonia
BETALOC ZOK
METOPROLOL SUCCINATE
Latvia
BETALOC ZOK
METOPROLOL SUCCINATE
Lithuania
BETALOC ZOK
METOPROLOL SUCCINATE
Poland
BETALOC ZOK
METOPROLOL SUCCINATE
Romania
BETALOC
METOPROLOL SUCCINATE
Czech Republic
BETALOC
METOPROLOL SUCCINATE
Estonia
BETALOC
METOPROLOL SUCCINATE
Ireland
BETALOC
METOPROLOL SUCCINATE
Latvia
BETALOC
METOPROLOL SUCCINATE
Poland
BETALOC
METOPROLOL SUCCINATE
Romania
BETALOC
METOPROLOL SUCCINATE
Slovakia
BETALOC
METOPROLOL SUCCINATE
United Kingdom
BI-ORALSUERO
GLUCOSE
Portugal
BI-ORALSUERO
GLUCOSE
Spain
BILIM
CONTRACT MANUFACTURING
Turkey
BINOSTO
SODIUM ALENDRONATE TRIHYDRATE
Germany
BIOGAIA
LACTOBACILLUS REUTERI PROTECTIS
Portugal
BISOPROLOL JABA
BISOPROLOL
Portugal
BROMISOL
BROMHEXINE
Libya
BROMISOL
BROMHEXINE
Tunisia
BUPIVACAINA
BUPIVACAINE
Italy
BUTAMIR
BUTAMIRATE CITRATE
Georgia
C LENS
CHLORHEXIDINE
Tunisia
C PLUS
VITAMIN C
Italy
CABRAL
PHENYRAMIDOL HYDROCHLORIDE
Georgia
CABRAL
PHENYRAMIDOL HYDROCHLORIDE
Libya
CABRAL
PHENYRAMIDOL HYDROCHLORIDE
Macedonia
CABRAL
PHENYRAMIDOL HYDROCHLORIDE
Turkey
CALCIDOS
CALCIUM CARBONATE
Libya
CALCIDOS
CALCIUM CARBONATE
Tunisia
CALCIUM PANTOTENAT
CALCIUM PANTHOTENATE
Czech Republic
CALCIUM PANTOTENAT
CALCIUM PANTHOTENATE
Slovakia
CALDEFIX
COLECALCIFEROL
Romania
CALMURID
UREA
Portugal
CALPEROS
CALCIUM CARBONATE
Libya
CALPEROS
CALCIUM CARBONATE
Luxembourg
CALPEROS
CALCIUM CARBONATE
Switzerland
CALPEROS
CALCIUM CARBONATE
Tunisia
CAR-GO CARDIO
CREATINE
Italy
CAR-GO
CREATINE
Italy
CARDICOR
BISOPROLOL
Italy
CARDIOVASC
LERCANIDIPINE HYDROCHLORIDE
Italy
CARNITONE
L-CARNITINE
Belarus
CARNITONE
L-CARNITINE
Kazakhstan
CARNITONE
L-CARNITINE
Russian Federation
CARVEDILOL JABA
CARVEDILOL
Portugal
CARZAP
AMLODIPINE
Portugal
CASENBIOTIC
LACTOBACILLUS REUTERI PROTECTIS
Portugal
CASENBIOTIC
LACTOBACILLUS REUTERI PROTECTIS
Spain
CASENDIET
NOT AVAILABLE
Spain
CASENFIBRA
MALTODEXTRIN
Georgia
CASENFIBRA
MALTODEXTRIN
Romania
CASENFIBRA
MALTODEXTRIN
Spain
CASENFILUS
LACTOBACILLUS ACIDOPHILUS
Spain
CASENGLICOL
MACROGOL
Spain
CASENLAX
MACROGOL
Belarus
CASENLAX
MACROGOL
Greece
CASENLAX
MACROGOL
Italy
CASENLAX
MACROGOL
Portugal
CASENLAX
MACROGOL
Spain
CASENLAX
MACROGOL
Turkey
CIDINE
CITINAPRIDE
Spain
CINAZYN
CINNARIZINE
Italy
CINKASA
MESALAZINE
Libya
CINKASA
MESALAZINE
Tunisia
CIPRASID
CIPROFLOXACIN HYDROCHLORIDE
Albania
CIPRASID
CIPROFLOXACIN HYDROCHLORIDE
Iraq
CIPRASID
CIPROFLOXACIN HYDROCHLORIDE
Libya
CIPRASID
CIPROFLOXACIN HYDROCHLORIDE
Turkey
CISTALGAN
FLAVOXATE HYDROCHLORIDE
Italy
CITRAFLEET
CITRIC ACID
Belgium
CITRAFLEET
CITRIC ACID
Denmark
CITRAFLEET
CITRIC ACID
Finland
CITRAFLEET
CITRIC ACID
Georgia
CITRAFLEET
CITRIC ACID
Germany
CITRAFLEET
CITRIC ACID
Greece
CITRAFLEET
CITRIC ACID
Iceland
CITRAFLEET
CITRIC ACID
Ireland
CITRAFLEET
CITRIC ACID
Italy
CITRAFLEET
CITRIC ACID
Kazakhstan
CITRAFLEET
CITRIC ACID
Luxembourg
CITRAFLEET
CITRIC ACID
Norway
CITRAFLEET
CITRIC ACID
Poland
CITRAFLEET
CITRIC ACID
Portugal
CITRAFLEET
CITRIC ACID
Romania
CITRAFLEET
CITRIC ACID
Spain
CITRAFLEET
CITRIC ACID
Sweden
CITRAFLEET
CITRIC ACID
Switzerland
CITRAFLEET
CITRIC ACID
Turkey
CITRAFLEET
CITRIC ACID
United Kingdom
CLARIREC
#N/A
Tunisia
CLAVERSAL
MESALAZINE
Germany
CLEANOMISIN
CLARITHROMYCIN
Azerbaijan
CLEANOMISIN
CLARITHROMYCIN
Georgia
CLEANOMISIN
CLARITHROMYCIN
Iraq
CLEANOMISIN
CLARITHROMYCIN
Libya
CLEANOMISIN
CLARITHROMYCIN
Turkey
CLEEN ENEMA
MONOBASIC SODIUM PHOSPHATE
Belgium
CLEEN ENEMA
MONOBASIC SODIUM PHOSPHATE
Denmark
CLEEN ENEMA
MONOBASIC SODIUM PHOSPHATE
Ireland
CLEEN ENEMA
MONOBASIC SODIUM PHOSPHATE
Luxembourg
CLEEN ENEMA
MONOBASIC SODIUM PHOSPHATE
United Kingdom
CLISMA FLEET
MONOBASIC SODIUM PHOSPHATE
Italy
CLOPIDOGREL
CLOPIDOGREL
Portugal
CLOXAM
CLOXAZOLAM
Portugal
COLCHICINE
COLCHICINE
Portugal
COLCHICUM
COLCHICINE
Iraq
COLCHICUM
COLCHICINE
Turkey
COLLOMACK
SALICYLIC ACID
Germany
COLLUXID
CHLORHEXIDINE
Tunisia
COMBODART
DUTASTERIDE TAMSULOSIN
Belgium
COMBODART
DUTASTERIDE TAMSULOSIN
Ireland
COMBODART
DUTASTERIDE TAMSULOSIN
Italy
COMBODART
DUTASTERIDE TAMSULOSIN
Luxembourg
COMBODART
DUTASTERIDE TAMSULOSIN
Portugal
COMBODART
DUTASTERIDE TAMSULOSIN
United Kingdom
CORIFEO
LERCANIDIPINE HYDROCHLORIDE
Germany
CORIPREN
LERCANIDIPINE HYDROCHLORIDE
Armenia
CORIPREN
LERCANIDIPINE HYDROCHLORIDE
Georgia
CORIPREN
LERCANIDIPINE HYDROCHLORIDE
Italy
CORIPREN
LERCANIDIPINE HYDROCHLORIDE
Kazakhstan
CORIPREN
LERCANIDIPINE HYDROCHLORIDE
Spain
CORIPREN
LERCANIDIPINE HYDROCHLORIDE
Ukraine
CORIPREN
LERCANIDIPINE HYDROCHLORIDE
Uzbekistan
CORTINASE
BUDESONIDE
Iraq
CORTINASE
BUDESONIDE
Libya
CORTINASE
BUDESONIDE
Sudan
CORTINASE
BUDESONIDE
Tanzania, United Republic of
CORTINASE
BUDESONIDE
Tunisia
CURZEN
CURCUMA
Italy
D 1000
VITAMIN D
Italy
DEFLAZACORTE
DEFLAZACORT
Portugal
DEFLU
PARACETAMOL
Turkey
DENTOSAN COLL
CHLORHEXIDINE
Italy
DENTOSAN DENTIF
CHLORHEXIDINE
Italy
DENTOSAN PARODONT
CHLORHEXIDINE
Italy
DENTOSAN SPAZZ
NOT AVAILABLE
Italy
DERMATRANS
NITROGLYCERIN
Spain
DERMOSALIC
BETAMETHASONE
Iraq
DERMOSALIC
BETAMETHASONE
Libya
DERMOSALIC
BETAMETHASONE
Tunisia
DERMOSONE
BETAMETHASONE
Libya
DERMOSONE
BETAMETHASONE
Tunisia
DEXABENE
DEXAMETHASONE
Germany
DIAMEZID
GLICLAZIDE
Senegal
DIAMEZID
GLICLAZIDE
Tunisia
DICLOPAL
DICLOFENAC
Libya
DICLOPAL
DICLOFENAC
Tunisia
DILLS
ESSENTIAL OILS
Romania
DINTOINA
PHENITOIN
Italy
DINTOINALE
SODIUM PHENYTOIN
Italy
DOLOBENE
IBUPROFEN
Germany
DOMPER
DOMPERIDONE
Libya
DOMPER
DOMPERIDONE
Tunisia
DONEPEZILO
DONEPEZIL
Portugal
DOXYLAMINE
#N/A
Tunisia
DUAGEN
DUTASTERIDE
Italy
DUAGEN
DUTASTERIDE
Portugal
DUODART
DUTASTERIDE TAMSULOSIN
Czech Republic
DUODART
DUTASTERIDE TAMSULOSIN
Finland
DUODART (GSK)
DUTASTERIDE TAMSULOSIN
Germany
DUODART
DUTASTERIDE TAMSULOSIN
Greece
DUODART
DUTASTERIDE TAMSULOSIN
Spain
DUODART
DUTASTERIDE TAMSULOSIN
Switzerland
DUODART
DUTASTERIDE TAMSULOSIN
Poland
ECHINACEA COMPLEX
ECHINACEA
Italy
ECOREX
ECONAZOLE
Iraq
ECOREX
ECONAZOLE
Libya
ECOREX
ECONAZOLE
Senegal
ECOREX
ECONAZOLE
Tunisia
EGOSTAR
COLECALCIFEROL
Portugal
ELEBIOTIC
LACTOBACILLUS SALIVARIUS PS7
Spain
ELIGARD
LEUPRORELIN ACETATE
Austria
ELIGARD
LEUPRORELIN ACETATE
Belarus
ELIGARD
LEUPRORELIN ACETATE
Belgium
ELIGARD
LEUPRORELIN ACETATE
Bulgaria
ELIGARD
LEUPRORELIN ACETATE
Czech Republic
ELIGARD
LEUPRORELIN ACETATE
Denmark
ELIGARD
LEUPRORELIN ACETATE
Finland
ELIGARD
LEUPRORELIN ACETATE
Georgia
ELIGARD
LEUPRORELIN ACETATE
Germany
ELIGARD
LEUPRORELIN ACETATE
Iceland
ELIGARD
LEUPRORELIN ACETATE
Ireland
ELIGARD
LEUPRORELIN ACETATE
Italy
ELIGARD
LEUPRORELIN ACETATE
Latvia
ELIGARD
LEUPRORELIN ACETATE
Lithuania
ELIGARD
LEUPRORELIN ACETATE
Luxembourg
ELIGARD
LEUPRORELIN ACETATE
Netherlands
ELIGARD
LEUPRORELIN ACETATE
Norway
ELIGARD
LEUPRORELIN ACETATE
Poland
ELIGARD
LEUPRORELIN ACETATE
Portugal
ELIGARD
LEUPRORELIN ACETATE
Romania
ELIGARD
LEUPRORELIN ACETATE
Russian Federation
ELIGARD
LEUPRORELIN ACETATE
Slovakia
ELIGARD
LEUPRORELIN ACETATE
Spain
ELIGARD
LEUPRORELIN ACETATE
Sweden
ELIGARD
LEUPRORELIN ACETATE
Switzerland
ELIGARD
LEUPRORELIN ACETATE
Turkey
ELIXTRA
APIXABAN
Iraq
ELIXTRA
APIXABAN
Libya
ELIXTRA
APIXABAN
Tunisia
ENEMA CASEN
MONOBASIC SODIUM PHOSPHATE
Spain
ENERZAIR
INDACATEROL
Portugal
ENTOCIR
BUDESONIDE
Italy
ENZYLIFE
MALTODEXTRIN
Italy
EOLIDE
BUDESONIDE
Iraq
EOLIDE
BUDESONIDE
Libya
EOLIDE
BUDESONIDE
Tunisia
ERY
ERYTHROMYCIN PROPIONATE
Luxembourg
ERYTHROCIN
ERYTHROMYCIN LACTOBIONATE
Switzerland
EUMILL
HAMAMELIS
Italy
EUPHON
ERYSIMUM
Portugal
EVIDOL
COLLAGEN PEPTIDES
Italy
EXOMUC
N-ACETYLCYSTEINE
Luxembourg
FALVIN
FENTICONAZOLE NITRATE
Italy
FEMLAX
MACROGOL
Spain
FENTICONAZOLE
FENTICONAZOLE NITRATE
Italy
FER PLUS
FERRIC OXIDE POLYMALTOSE
Libya
FER PLUS
FERRIC OXIDE POLYMALTOSE
Tunisia
FINXTA
FINASTERIDE
Poland
FISIOENEMA
SODIUM CHLORIDE
Spain
FITOGYN
GLYCINE
Spain
FLATORIL
CLEBOPRIDE MALATE
Spain
FLEET ENEMA
MONOBASIC SODIUM PHOSPHATE
Georgia
FLEET ENEMA
MONOBASIC SODIUM PHOSPHATE
Kazakhstan
FLEET ENEMA
MONOBASIC SODIUM PHOSPHATE
Portugal
FLOSA
PSYLLIUM
Germany
FLUDERM
FLUCONAZOLE
Iraq
FLUDERM
FLUCONAZOLE
Tunisia
FLUSKIN
FLUCINONIDE
Tunisia
FOCUS
BILBERRY EXTRACT
Kazakhstan
FORTACIN
LIDOCAINE
Germany
FORTACIN
LIDOCAINE
Italy
FORTACIN
LIDOCAINE
Portugal
See products/voir produits
France
FUCITHALMIC
FUSIDIC ACID
Switzerland
GABA
GABAPENTIN
Tunisia
GARLIFE
GARLIC
Italy
GASTRUS
LACTOBACILLUS REUTERI GASTRUS
Spain
GENURIN
FLAVOXATE HYDROCHLORIDE
Italy
GINKOR
GINKGO BILOBA
Armenia
GINKOR
GINKGO BILOBA
Belarus
GINKOR
GINKGO BILOBA
Georgia
GINKOR
GINKGO BILOBA
Latvia
GINKOR
GINKGO BILOBA
Lithuania
GINKOR
GINKGO BILOBA
Russian Federation
GINKOR
GINKGO BILOBA
Tunisia
GINKOR
GINKGO BILOBA
Ukraine
GLUCOSAMINA
GLUCOSAMINE SULFATE
Italy
GLYSS
GLYCEROL
Libya
GLYSS
GLYCEROL
Tunisia
GOLDIX
DEXTROMETHORPHAN
Libya
GOLDIX
DEXTROMETHORPHAN
Tunisia
GURONSAN
ASCORBIC ACID
Portugal
GYNO-LOMEXIN
FENTICONAZOLE NITRATE
Turkey
GYNOXIN
FENTICONAZOLE NITRATE
Belgium
GYNOXIN
FENTICONAZOLE NITRATE
Luxembourg
GYNOXIN
FENTICONAZOLE NITRATE
Poland
GYNOXIN
FENTICONAZOLE NITRATE
Ukraine
HEDERA HELIX
HEDERA HELIX EXTRACT
Libya
HEDERA HELIX
HEDERA HELIX EXTRACT
Tunisia
HEXALYSE
BICLOTYMOL
Armenia
HEXALYSE
BICLOTYMOL
Belarus
HEXALYSE
BICLOTYMOL
Georgia
HEXALYSE
BICLOTYMOL
Kazakhstan
HEXALYSE
BICLOTYMOL
Mongolia
HEXALYSE
BICLOTYMOL
Russian Federation
HEXALYSE
BICLOTYMOL
Turkmenistan
HEXALYSE
BICLOTYMOL
Ukraine
HEXALYSE
BICLOTYMOL
Uzbekistan
HEXASPRAY
BICLOTYMOL
Armenia
HEXASPRAY
BICLOTYMOL
Belarus
HEXASPRAY
BICLOTYMOL
Georgia
HEXASPRAY
BICLOTYMOL
Kazakhstan
HEXASPRAY
BICLOTYMOL
Luxembourg
HEXASPRAY
BICLOTYMOL
Mongolia
HEXASPRAY
BICLOTYMOL
Russian Federation
HEXASPRAY
BICLOTYMOL
Tunisia
HEXASPRAY
BICLOTYMOL
Turkmenistan
HEXASPRAY
BICLOTYMOL
Ukraine
HEXASPRAY
BICLOTYMOL
Uzbekistan
HEXATOUX
CD-CYANIDIN
Georgia
HIPPURIN
METHENAMINE HIPPURATE
Georgia
HIPPURIN
METHENAMINE HIPPURATE
Turkey
HOSPER
VITAMINS
Kenya
HOSPER
VITAMINS
Sudan
HOSPER
VITAMINS
Tanzania, United Republic of
HYLAK
LACTOBACILLUS HELVETICUS
Germany
HYTRIN
TERAZOSIN MONOHYDROCHLORIDE DIHYDRATE
Switzerland
IALUFLEX
CHONDROITIN SULFATE
Libya
IALUFLEX
CHONDROITIN SULFATE
Tunisia
IALUFRESH
HYALURONIC ACID
Tanzania, United Republic of
IALUFRESH
HYALURONIC ACID
Tunisia
IALUGYN
HYALURONIC ACID
Iraq
IALUGYN
HYALURONIC ACID
Kenya
IALUGYN
HYALURONIC ACID
Libya
IALUGYN
HYALURONIC ACID
Tanzania, United Republic of
IALUGYN
HYALURONIC ACID
Tunisia
IALUPROCT
HYALURONIC ACID
Kenya
IALUPROCT
HYALURONIC ACID
Libya
IALUPROCT
HYALURONIC ACID
Tanzania, United Republic of
IALUPROCT
HYALURONIC ACID
Tunisia
IALUSKIN
HYALURONIC ACID
Iraq
IALUSKIN
HYALURONIC ACID
Libya
IALUSKIN
HYALURONIC ACID
Tunisia
IALUSOF
XYLITOL
Libya
IALUSOF
XYLITOL
Tunisia
IBU
IBUPROFEN
Turkey
IMIDAZYL
NAPHAZOLINE
Italy
INDOPAL
INDOMETACIN
Iraq
INDOPAL
INDOMETACIN
Libya
INDUSIL
COBAMAMIDE
Italy
INFADOLAN
ERGOCALCIFEROL
Czech Republic
INFADOLAN
ERGOCALCIFEROL
Slovakia
IPPSIUM
ESOMEPRAZOLE
Libya
IPPSIUM
ESOMEPRAZOLE
Tunisia
IRBEXTRA
#N/A
Tunisia
ISOFRA
FRAMYCETIN SULFATE
Georgia
ISOFRA
FRAMYCETIN SULFATE
Kazakhstan
ISOFRA
FRAMYCETIN SULFATE
Mongolia
ISOFRA
FRAMYCETIN SULFATE
Russian Federation
ISOFRA
FRAMYCETIN SULFATE
Turkmenistan
ISOFRA
FRAMYCETIN SULFATE
Ukraine
ISOFRA
FRAMYCETIN SULFATE
Uzbekistan
ITRAGYN
ITRACONAZOLE
Tunisia
JABA B12
COBAMAMIDE
Portugal
JELNU
DUTASTERIDE TAMSULOSIN
Italy
JHP-ROEDLER
MINT OIL
Germany
JUTEO
DUTASTERIDE TAMSULOSIN
Portugal
KENTERA
OXYBUTININ
Turkey
KREOFLAT
PANCREATIN
Azerbaijan
KREVAL
BUTAMIRATE CITRATE
Azerbaijan
KREVAL
BUTAMIRATE CITRATE
Turkey
KREVAL
BUTAMIRATE CITRATE
Vietnam
KRILLING
KRILL OIL
Italy
KROVANEG
LANSOPRAZOLE
Italy
KUROVENT
FORMOTEROL FUMARATE DIHYDRATE
Italy
KURTSAN
CONTRACT MANUFACTURING
Turkey
LACDIGEST
TILACTASE
Italy
LACDIGEST
TILACTASE
Switzerland
LACTO
SPOROLACTOBACILLUS
Italy
LACTULOSE
LACTULOSE
Senegal
LACTULOSE
LACTULOSE
Tunisia
LECTIL
BETHAISTINE DICHLORHYDRATE
Luxembourg
LERCADIP
LERCANIDIPINE HYDROCHLORIDE
Greece
LERCADIP
LERCANIDIPINE HYDROCHLORIDE
Italy
LERCADIP
LERCANIDIPINE HYDROCHLORIDE
Turkey
LERCAN
LERCANIDIPINE HYDROCHLORIDE
Poland
LERCANIDIPIN-OMNIAPHARM
LERCANIDIPINE HYDROCHLORIDE
Germany
LERCANIDIPINA JABA
LERCANIDIPINE HYDROCHLORIDE
Portugal
LERCANIDIPINE
LERCANIDIPINE HYDROCHLORIDE
United Kingdom
LERCANIDIPINO
LERCANIDIPINE HYDROCHLORIDE
Spain
LERCAPREL
LERCANIDIPINE HYDROCHLORIDE
Greece
LERCAPREL
LERCANIDIPINE HYDROCHLORIDE
Italy
LERCAPREL
LERCANIDIPINE HYDROCHLORIDE
Poland
LERCAPRESS
LERCANIDIPINE HYDROCHLORIDE
Spain
LERCARIL
LERCANIDIPINE HYDROCHLORIDE
Ireland
LERDIP
LERCANIDIPINE HYDROCHLORIDE
Netherlands
LERPIN
LERCANIDIPINE HYDROCHLORIDE
Czech Republic
LERTEC
LERCANIDIPINE HYDROCHLORIDE
Netherlands
LERZAM
LERCANIDIPINE HYDROCHLORIDE
Spain
LEVETIRACETAM
LEVETIRACETAM
Portugal
LEVONIDIN
LEVOFLOXACIN HEMIHYDRATE
Albania
LEVONIDIN
LEVOFLOXACIN HEMIHYDRATE
Azerbaijan
LEVONIDIN
LEVOFLOXACIN HEMIHYDRATE
Georgia
LEVONIDIN
LEVOFLOXACIN HEMIHYDRATE
Iraq
LEVONIDIN
LEVOFLOXACIN HEMIHYDRATE
Libya
LEVONIDIN
LEVOFLOXACIN HEMIHYDRATE
Turkey
LEVOREC
#N/A
Tunisia
LIBA
CONTRACT MANUFACTURING
Turkey
LIPOTALON
DEXAMETHASONE PALMITATE
Germany
LIPOVITAN
CHOLINE
Czech Republic
LIPOVITAN
CHOLINE
Slovakia
LISINA
L-LYSINE
Italy
LIVAZO
PITAVASTATIN
Armenia
LIVAZO
PITAVASTATIN
Belarus
LIVAZO
PITAVASTATIN
Georgia
LIVAZO
PITAVASTATIN
Germany
LIVAZO
PITAVASTATIN
Greece
LIVAZO
PITAVASTATIN
Kazakhstan
LIVAZO
PITAVASTATIN
Portugal
LIVAZO
PITAVASTATIN
Russian Federation
LIVAZO
PITAVASTATIN
Spain
LIVAZO
PITAVASTATIN
Switzerland
LIVAZO
PITAVASTATIN
Ukraine
LOCALYN
FLUOCINOLONE ACETONIDE
Italy
LOGIMAT
METOPROLOL SUCCINATE
Belgium
LOGIMAT
METOPROLOL SUCCINATE
Luxembourg
LOGIMAX
METOPROLOL SUCCINATE
Finland
LOGIMAX
METOPROLOL SUCCINATE
Greece
LOGIMAX
METOPROLOL SUCCINATE
Iceland
LOGIMAX
METOPROLOL SUCCINATE
Spain
LOGIMAX
METOPROLOL SUCCINATE
Sweden
LOGIMAX
METOPROLOL SUCCINATE
Switzerland
LOMEXIN
FENTICONAZOLE NITRATE
Armenia
LOMEXIN
FENTICONAZOLE NITRATE
Belarus
LOMEXIN
FENTICONAZOLE NITRATE
Bulgaria
LOMEXIN
FENTICONAZOLE NITRATE
Czech Republic
LOMEXIN
FENTICONAZOLE NITRATE
Estonia
LOMEXIN
FENTICONAZOLE NITRATE
Georgia
LOMEXIN
FENTICONAZOLE NITRATE
Greece
LOMEXIN
FENTICONAZOLE NITRATE
Italy
LOMEXIN
FENTICONAZOLE NITRATE
Kazakhstan
LOMEXIN
FENTICONAZOLE NITRATE
Latvia
LOMEXIN
FENTICONAZOLE NITRATE
Lithuania
LOMEXIN
FENTICONAZOLE NITRATE
Moldova
LOMEXIN
FENTICONAZOLE NITRATE
Romania
LOMEXIN
FENTICONAZOLE NITRATE
Russian Federation
LOMEXIN
FENTICONAZOLE NITRATE
Slovakia
LOMEXIN
FENTICONAZOLE NITRATE
Spain
LOMEXIN
FENTICONAZOLE NITRATE
Ukraine
LOPRESOR
METOPROLOL TARTRATE
Germany
LOPRESOR
METOPROLOL TARTRATE
Greece
LOPRESOR
METOPROLOL TARTRATE
Spain
LOSARTAN JABA
LOSARTAN
Portugal
LOSARTAN+HCTZ JABA
LOSARTAN
Portugal
LOSFERRON
FERROUS GLUCONATE
Spain
LOVINACOR
LOVASTATIN
Italy
MAGNESIO SUPREMO
MAGNESIUM CARBONATE
Italy
MAGNESIO SUPREMO
MAGNESIUM CARBONATE
Portugal
MAGNESIO SUPREMO
MAGNESIUM CARBONATE
Switzerland
MAXIUS
TIBEZONIUM IODIDE
Portugal
MAYFEX
FEXOFENADINE
Iraq
MAYFEX
FEXOFENADINE
Kosovo
MAYFEX
FEXOFENADINE
Macedonia
MAYFEX
FEXOFENADINE
Turkey
MEMANTINA
MEMANTINE
Portugal
MEPIVACAINA
MEPIVACAINE
Italy
METPAMID
METOCLOPRAMIDE
Libya
METPAMID
METOCLOPRAMIDE
Turkey
METRONIDAZOLE
METRONIDAZOLE
Libya
METRONIDAZOLE
METRONIDAZOLE
Tunisia
MG 2 PLUS
MAGNESIUM PIDOLATE
Tunisia
MG
MAGNESIUM
Tunisia
MICROLAX
SODIUM CITRATE
Portugal
MICTONORM
FOSFOMYCIN
Czech Republic
MICTONORM
FOSFOMYCIN
Slovakia
MICTONORM
FOSFOMYCIN
Turkey
MINOSTYL
MINOXIDIL
Iraq
MINOSTYL
MINOXIDIL
Libya
MIOREK
PHENYRAMIDOL HYDROCHLORIDE
Azerbaijan
MIRFULAN
ECTOIN
Germany
MIRTAZAPINA JABA
MIRTAZEPINE
Portugal
MOBLOC
METOPROLOL SUCCINATE
Germany
MOMENT
IBUPROFEN
Tunisia
MONA LISA
NOT AVAILABLE
Portugal
MQC
METHYLSULFONYLMETHANE
Italy
MUCOSOL
CARBOCISTEINE
Libya
MUCOSOL
CARBOCISTEINE
Tunisia
MUVAGYN
LACTOBACILLUS GASSERI
Georgia
MUVAGYN
LACTOBACILLUS GASSERI
Italy
MUVAGYN
LACTOBACILLUS GASSERI
Spain
MYCOCLEAR
CLOTRIMAZOLE
Portugal
MYCOREX
CICLOPIROX OLAMINE
Tunisia
MYOLIFE
MYO-INOSITOL
Italy
N-FESS
MONTELUKAST SODIUM
Albania
N-FESS
MONTELUKAST SODIUM
Georgia
N-FESS
MONTELUKAST SODIUM
Iraq
N-FESS
MONTELUKAST SODIUM
Kyrgyzstan
N-FESS
MONTELUKAST SODIUM
Tunisia
N-FESS
MONTELUKAST SODIUM
Turkey
NALCROM
SODIUM CROMOGLICATE
Italy
NAPROSYN
NAPROXEN
Italy
NAZOFIX
MOMETASONE
Albania
NAZOFIX
MOMETASONE
Georgia
NAZOFIX
MOMETASONE
Iraq
NAZOFIX
MOMETASONE
Turkey
NAZOFIX
MOMETASONE
Vietnam
NEBINAD
NEBIVOLOL
Poland
NEO CODION
CODEINE CAMPHOSULFONATE
Luxembourg
NEO
CARBIMAZOLE
Switzerland
NEURODOL
HALOPERIDOL
Senegal
NEURODOL
HALOPERIDOL
Tunisia
NIMESULIDE JABASULIDE
NIMESULIDE
Portugal
NON PROMO
ACETYLSALICYLIC ACID
Czech Republic
NON PROMO
ACETYLSALICYLIC ACID
Slovakia
NORMOC
BROMAZEPAM
Germany
NOTOS COMBI
BUDESONIDE
Iraq
NOTOS COMBI
BUDESONIDE
Libya
NOTOS COMBI
BUDESONIDE
Tunisia
NOTOS
FORMOTEROL FUMARATE DIHYDRATE
Libya
NOTOS
FORMOTEROL FUMARATE DIHYDRATE
Tunisia
NYDA
DIMETHICONE
Spain
OLIO DI BORRAGINE
BORAGE OIL
Italy
OLLAFAX
OLANZAPINE
Azerbaijan
OLLAFAX
OLANZAPINE
Georgia
OLLAFAX
OLANZAPINE
Turkey
OMEGA SILVER
POLYUNSATURATED OMEGA-3 FATTY ACIDS
Italy
ORAL REHYDRATION SOLUTIONS
GLUCOSE
Portugal
ORAL REHYDRATION SOLUTIONS
GLUCOSE
Spain
ORTOTON
METHOCARBAMOL
Germany
ORTOTON
METHOCARBAMOL
Tunisia
OSTEOPLUS
CALCIUM CARBONATE
Germany
OSTEZOLEN
ZOLENDRIC ACID
Libya
OSTEZOLEN
ZOLENDRIC ACID
Turkey
OTOFA
RIFAMYCIN
Armenia
OTOFA
RIFAMYCIN
Azerbaijan
OTOFA
RIFAMYCIN
Belarus
OTOFA
RIFAMYCIN
Georgia
OTOFA
RIFAMYCIN
Kazakhstan
OTOFA
RIFAMYCIN
Luxembourg
OTOFA
RIFAMYCIN
Mongolia
OTOFA
RIFAMYCIN
Russian Federation
OTOFA
RIFAMYCIN
Tunisia
OTOFA
RIFAMYCIN
Turkmenistan
OTOFA
RIFAMYCIN
Ukraine
OTOFA
RIFAMYCIN
Uzbekistan
PAIDOLAX
GLYCEROL
Georgia
PAIDOLAX
GLYCEROL
Kazakhstan
PAIDOLAX
GLYCEROL
Spain
PAINOFEN
IBUPROFEN
Libya
PAINOFEN
IBUPROFEN
Tunisia
PANKREOFLAT
PANCREATIN
Turkey
PANTOPRAZOLO
PANTOPRAZOLE
Spain
PENNSAID
DICLOFENAC
Italy
PEPTAZOL
PANTOPRAZOLE
Italy
PERIDO NATURAL
GINGER
Italy
PERIDON
DOMPERIDONE
Italy
PHOSPHONEUROS
PHOSPHORIC ACID
Tunisia
PHOSPHORAL
SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE
Finland
PHOSPHORAL
SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE
Norway
PHOSPHORAL
SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE
Sweden
PHOSPHOSODA
SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE
Belgium
PHOSPHOSODA
SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE
Germany
PHOSPHOSODA
SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE
Ireland
PHOSPHOSODA
SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE
Luxembourg
PHOSPHOSODA
SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE
Portugal
PHOSPHOSODA
SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE
Spain
PHOSPHOSODA
SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE
Turkey
PHOSPHOSODA
SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE
United Kingdom
PHYSIOLOGICA
SODIUM CHLORIDE
Portugal
PIVINORM
PIVMECILLINAM HYDROCHLORIDE
Czech Republic
POLYDEXA
NEOMYCIN SULFATE
Armenia
POLYDEXA
NEOMYCIN SULFATE
Belarus
POLYDEXA
NEOMYCIN SULFATE
Georgia
POLYDEXA
NEOMYCIN SULFATE
Kazakhstan
POLYDEXA
NEOMYCIN SULFATE
Luxembourg
POLYDEXA
NEOMYCIN SULFATE
Mongolia
POLYDEXA
NEOMYCIN SULFATE
Russian Federation
POLYDEXA
NEOMYCIN SULFATE
Tunisia
POLYDEXA
NEOMYCIN SULFATE
Turkmenistan
POLYDEXA
NEOMYCIN SULFATE
Ukraine
POLYDEXA
NEOMYCIN SULFATE
Uzbekistan
POTASSIO GLUCONATO
POTASSIUM GLUCONATE
Italy
PRADIS
METOCLOPRAMIDE
Libya
PRADIS
METOCLOPRAMIDE
Tunisia
PRAVASTATINA JABA
PRAVASTATIN
Portugal
PREPAGEL
AESCIN
Turkey
PRILIA
LIDOCAINE
Libya
PRILIA
LIDOCAINE
Sudan
PRILIA
LIDOCAINE
Tanzania, United Republic of
PRILIA
LIDOCAINE
Tunisia
PROCTO-GLYVENOL
TRIBENOSIDE
Czech Republic
PROCTO-GLYVENOL
TRIBENOSIDE
Latvia
PROCTO-GLYVENOL
TRIBENOSIDE
Lithuania
PROCTO-GLYVENOL
TRIBENOSIDE
Poland
PROCTO-GLYVENOL
TRIBENOSIDE
Portugal
PROCTO-GLYVENOL
TRIBENOSIDE
Romania
PROCTO-GLYVENOL
TRIBENOSIDE
Russian Federation
PROCTO-GLYVENOL
TRIBENOSIDE
Slovakia
PROCTO-GLYVENOL
TRIBENOSIDE
Turkey
PROCTO-GLYVENOL
TRIBENOSIDE
Ukraine
PROCTOLYN
0
Italy
PROGASTIM
OMEPRAZOL
Poland
PROPYCIL
PROPYLTHIOURACIL
Turkey
PROVOC
ZINC
Kenya
PROVOC
ZINC
Sudan
PROVOC
ZINC
Tanzania, United Republic of
PRUREX
CROTAMITON
Libya
PRUREX
CROTAMITON
Tunisia
PSORIASONE
BETAMETHASONE
Iraq
PSORIASONE
BETAMETHASONE
Libya
PSORIASONE
BETAMETHASONE
Sudan
PSORIASONE
BETAMETHASONE
Tanzania, United Republic of
PSORIASONE
BETAMETHASONE
Tunisia
PURINOL
METHENAMINE ANHYDROMETHYLENECITRATE
Georgia
PURINOL
METHENAMINE ANHYDROMETHYLENECITRATE
Turkey
Q10
COENZYME Q10
Italy
QUDESAN
COENZYME Q10
Belarus
QUDESAN
COENZYME Q10
Kazakhstan
QUDESAN
COENZYME Q10
Mongolia
QUDESAN
COENZYME Q10
Russian Federation
QUDESAN
COENZYME Q10
Ukraine
QUERCETINE
NOT AVAILABLE
Libya
QUERCETINE
NOT AVAILABLE
Tunisia
RAMIPRIL JABA
RAMIPRIL
Portugal
REAGILA
CARIPRAZINE
Austria
REAGILA
CARIPRAZINE
Belgium
REAGILA
CARIPRAZINE
Denmark
REAGILA
CARIPRAZINE
Finland
REAGILA
CARIPRAZINE
Germany
REAGILA
CARIPRAZINE
Greece
REAGILA
CARIPRAZINE
Iceland
REAGILA
CARIPRAZINE
Ireland
REAGILA
CARIPRAZINE
Italy
REAGILA
CARIPRAZINE
Luxembourg
REAGILA
CARIPRAZINE
Netherlands
REAGILA
CARIPRAZINE
Norway
REAGILA
CARIPRAZINE
Portugal
REAGILA
CARIPRAZINE
Spain
REAGILA
CARIPRAZINE
Sweden
REAGILA
CARIPRAZINE
Switzerland
REAGILA
CARIPRAZINE
United Kingdom
REBUTESTIN
BUTYRIC ACID
Poland
RECOFLUID
CARBOCISTEINE
Italy
RECOPROX
SERENOA REPENS EXTRACT
Italy
RECOSYN
SODIUM HYALURONATE
Germany
RECOTUSS
DEXTROMETHORPHAN
Italy
RELAXIL
THIOCOLCHISODIDE
Tunisia
REUFLOR
LACTOBACILLUS REUTERI PROTECTIS
Italy
REUTERI
LACTOBACILLUS REUTERI PROTECTIS
Spain
REXTAT
LOVASTATIN
Italy
RHINOPRONT
PSEUDOEPHEDRINE HYDROCHLORIDE
Germany
RINOSAL
FLUTICASONE
Iraq
RINOSAL
FLUTICASONE
Libya
RINOSAL
FLUTICASONE
Sudan
RINOSAL
FLUTICASONE
Tanzania, United Republic of
RINOSAL
FLUTICASONE
Tunisia
RIZMOIC
#N/A
Spain
RODIOLA ROSEA
RODIOLA ROSEA ROOT EXTRACT
Italy
RUNOMEX
MELOXICAM
Azerbaijan
RUNOMEX
MELOXICAM
Georgia
RUNOMEX
MELOXICAM
Iraq
RUNOMEX
MELOXICAM
Kyrgyzstan
RUNOMEX
MELOXICAM
Libya
RUNOMEX
MELOXICAM
Turkey
RUPAFIN
RUPATADINE
Italy
RYBILKA
FISH OIL
Czech Republic
RYBILKA
FISH OIL
Slovakia
SAFFROX
CROCUS SATIVUS
Portugal
SALAZA
MESALAZINE
Poland
SALAZOPIRINA
SULFASALAZINE
Portugal
SAVEROL
SALICYLIC ACID
Tunisia
SAW PALMETTO
SERENOA REPENS EXTRACT
Italy
SELENIO
SELENIUM
Italy
SELOKEEN ZOC
METOPROLOL SUCCINATE
Netherlands
SELOKEN ZOK
METOPROLOL SUCCINATE
Finland
SELOKEN ZOK
METOPROLOL SUCCINATE
Iceland
SELOKEN ZOK
METOPROLOL SUCCINATE
Norway
SELOKEN ZOK
METOPROLOL SUCCINATE
Sweden
SELOKEN
METOPROLOL TARTRATE
Austria
SELOKEN
METOPROLOL TARTRATE
Belgium
SELOKEN
METOPROLOL TARTRATE
Finland
SELOKEN
METOPROLOL TARTRATE
Iceland
SELOKEN
METOPROLOL TARTRATE
Italy
SELOKEN
METOPROLOL TARTRATE
Luxembourg
SELOKEN
METOPROLOL TARTRATE
Netherlands
SELOKEN
METOPROLOL TARTRATE
Norway
SELOKEN
METOPROLOL TARTRATE
Sweden
SELOZOK
METOPROLOL SUCCINATE
Belgium
SELOZOK
METOPROLOL SUCCINATE
Denmark
SELOZOK
METOPROLOL SUCCINATE
Norway
SERACTIL
DEXIBUPROFEN
Portugal
SICORTEN
HALOMETASONE MONOHYDRATE
Switzerland
SILDENAFIL
SILDENAFIL
Portugal
SILISKIN
SILICONE ELASTOMER
Iraq
SILISKIN
SILICONE ELASTOMER
Tunisia
SILODOSIN
SILODOSIN
Czech Republic
SILODOSIN
SILODOSIN
Poland
SILODOSIN
SILODOSIN
Portugal
SILODYX
SILODOSIN
Belgium
SILODYX
SILODOSIN
Luxembourg
SILODYX
SILODOSIN
Netherlands
SORBENOR
ARGININE ASPARTATE
Spain
SORECA
SOLIFENACINE
Poland
SPASURET
FLAVOXATE HYDROCHLORIDE
Germany
SPESICOR
METOPROLOL SUCCINATE
Finland
SPIRULIFE
SPIRULINA PLATENSIS SEAWEED
Italy
SPORALIM
TOLNAFTATE
Tunisia
SPORTVIS
HYALURONIC ACID
Germany
STERIDINE
ETHANOL
Tunisia
STILIZAN
TRIFLUOPERAZINE
Turkey
SULFARLEM
ANETHOLE TRITHIONE
Switzerland
SYNFLEX
SODIUM NAPROXEN
Italy
SYNTARIS
FLUNISOLIDE
Italy
TADALAFIL
TADALAFIL
Portugal
TALLIS
TERBINAFINE HYDROCHLORIDE
Iraq
TALLIS
TERBINAFINE HYDROCHLORIDE
Libya
TALLIS
TERBINAFINE HYDROCHLORIDE
Tunisia
TELEFIL
#N/A
Italy
TERGYNAN
METRONIDAZOLE
Armenia
TERGYNAN
METRONIDAZOLE
Azerbaijan
TERGYNAN
METRONIDAZOLE
Belarus
TERGYNAN
METRONIDAZOLE
Georgia
TERGYNAN
METRONIDAZOLE
Kazakhstan
TERGYNAN
METRONIDAZOLE
Luxembourg
TERGYNAN
METRONIDAZOLE
Moldova
TERGYNAN
METRONIDAZOLE
Mongolia
TERGYNAN
METRONIDAZOLE
Romania
TERGYNAN
METRONIDAZOLE
Russian Federation
TERGYNAN
METRONIDAZOLE
Tajikistan
TERGYNAN
METRONIDAZOLE
Tunisia
TERGYNAN
METRONIDAZOLE
Turkmenistan
TERGYNAN
METRONIDAZOLE
Ukraine
TERGYNAN
METRONIDAZOLE
Uzbekistan
TERMINUS
TERBINAFINE HYDROCHLORIDE
Albania
TERMINUS
TERBINAFINE HYDROCHLORIDE
Azerbaijan
TERMINUS
TERBINAFINE HYDROCHLORIDE
Iraq
TERMINUS
TERBINAFINE HYDROCHLORIDE
Kenya
TERMINUS
TERBINAFINE HYDROCHLORIDE
Kosovo
TERMINUS
TERBINAFINE HYDROCHLORIDE
Libya
TERMINUS
TERBINAFINE HYDROCHLORIDE
Turkey
TERMINUS
TERBINAFINE HYDROCHLORIDE
Vietnam
THEO_DUR
THEOPHYLLINE
Italy
THERMOVE
ETOFENAMATE
Georgia
THERMOVE
ETOFENAMATE
Turkey
TILL
TRICLOSAN
Tunisia
TINSERC
BETHAISTINE DICHLORHYDRATE
Azerbaijan
TINSERC
BETHAISTINE DICHLORHYDRATE
Iraq
TINSERC
BETHAISTINE DICHLORHYDRATE
Turkey
TOLZURIN
TOLTERODINE
Poland
TORA_DOL
KETOROLAC TROMETHAMINE
Italy
TRANSACT LAT
FLURBIPROFEN
Portugal
TRANSACT_LAT
FLURBIPROFEN
Italy
TRETINAC
ISOTRETINOIN
Switzerland
TUSSIPAX
DEXTROMETHORPHAN
Libya
TUSSIPAX
DEXTROMETHORPHAN
Tunisia
ULCERMIN
SUCRALFATE
Portugal
UPROX
TAMSULOSIN
Poland
URISPAS
FLAVOXATE HYDROCHLORIDE
Ireland
URISPAS
FLAVOXATE HYDROCHLORIDE
Lithuania
URISPAS
FLAVOXATE HYDROCHLORIDE
Netherlands
URISPAS
FLAVOXATE HYDROCHLORIDE
Portugal
URISPAS
FLAVOXATE HYDROCHLORIDE
Switzerland
URISPAS
FLAVOXATE HYDROCHLORIDE
Turkey
URISPAS
FLAVOXATE HYDROCHLORIDE
United Kingdom
UROCIT
POTASSIUM CITRATE
Switzerland
UROJABA
SERENOA REPENS EXTRACT
Portugal
URONID
FLAVOXATE HYDROCHLORIDE
Spain
UROREC
SILODOSIN
Armenia
UROREC
SILODOSIN
Azerbaijan
UROREC
SILODOSIN
Belarus
UROREC
SILODOSIN
Bulgaria
UROREC
SILODOSIN
Czech Republic
UROREC
SILODOSIN
Estonia
UROREC
SILODOSIN
Georgia
UROREC
SILODOSIN
Germany
UROREC
SILODOSIN
Greece
UROREC
SILODOSIN
Ireland
UROREC
SILODOSIN
Italy
UROREC
SILODOSIN
Kazakhstan
UROREC
SILODOSIN
Latvia
UROREC
SILODOSIN
Lithuania
UROREC
SILODOSIN
Moldova
UROREC
SILODOSIN
Poland
UROREC
SILODOSIN
Portugal
UROREC
SILODOSIN
Romania
UROREC
SILODOSIN
Russian Federation
UROREC
SILODOSIN
Slovakia
UROREC
SILODOSIN
Spain
UROREC
SILODOSIN
Switzerland
UROREC
SILODOSIN
Tunisia
UROREC
SILODOSIN
Turkey
UROREC
SILODOSIN
Ukraine
UROREC
SILODOSIN
Uzbekistan
UTROGESTAN
PROGESTERONE
Portugal
VAGILEN
METRONIDAZOLE
Iraq
VAGILEN
METRONIDAZOLE
Libya
VAGILEN
METRONIDAZOLE
Tunisia
VALETOL
PROPYPHENAZONE
Czech Republic
VALETOL
PROPYPHENAZONE
Slovakia
VALONTAN
DIMENHYDRINATE
Italy
VALOXINE
VALPROIC ACID
Libya
VALOXINE
VALPROIC ACID
Tunisia
VASOPROST
ALPROSTADIL
Portugal
VERAL OTC
DICLOFENAC
Czech Republic
VERAL OTC
DICLOFENAC
Slovakia
VERAL RX
DICLOFENAC
Czech Republic
VERAL RX
DICLOFENAC
Slovakia
VERAX
BENZYDAMINE
Tunisia
VERTIX
BETHAISTINE DICHLORHYDRATE
Poland
VETORON
BETA CAROTENE
Belarus
VETORON
BETA CAROTENE
Kazakhstan
VETORON
BETA CAROTENE
Russian Federation
VILDAGLIPTINA
VILDAGLIPTIN
Portugal
VIRIREC
ALPROSTADIL
Spain
VITA C
ASCORBIC ACID
Libya
VITA C
ASCORBIC ACID
Tunisia
VITAMINE A
VITAMIN A
Tunisia
VITAMINE C
VITAMIN C
Libya
VITAMINE D3
CHOLECALCIFEROL
Armenia
VITAMINE D3
CHOLECALCIFEROL
Belarus
VITAMINE D3
CHOLECALCIFEROL
Luxembourg
VITAMINE D3
CHOLECALCIFEROL
Tunisia
VITAROS
ALPROSTADIL
Greece
VITAROS
ALPROSTADIL
Ireland
VITAROS
ALPROSTADIL
Portugal
VITAROS
ALPROSTADIL
Romania
WILD YAM
VILLOSA DIOSCOREA ROOT EXTRACT
Italy
XIMVE
SIMVASTATIN
Poland
XITIX
ASCORBIC ACID
Germany
XTIOVA
TIOTROPIUM BROMIDE
Iraq
XTIOVA
TIOTROPIUM BROMIDE
Libya
XTIOVA
TIOTROPIUM BROMIDE
Tunisia
YENIZIN
CETIRIZINE
Albania
YENIZIN
CETIRIZINE
Azerbaijan
YENIZIN
CETIRIZINE
Libya
YENIZIN
CETIRIZINE
Turkey
YODUK
POTASSIUM IODIDE
Spain
Z ZOLE
ALBENDAZOLE
Libya
Z ZOLE
ALBENDAZOLE
Tunisia
ZANEDIP
LERCANIDIPINE HYDROCHLORIDE
Italy
ZANERIL
LERCANIDIPINE HYDROCHLORIDE
Greece
ZANEXTRA
LERCANIDIPINE HYDROCHLORIDE
Tunisia
ZANICOR
LERCANIDIPINE HYDROCHLORIDE
Portugal
ZANIDIP
LERCANIDIPINE HYDROCHLORIDE
Armenia
ZANIDIP
LERCANIDIPINE HYDROCHLORIDE
Austria
ZANIDIP
LERCANIDIPINE HYDROCHLORIDE
Belarus
ZANIDIP
LERCANIDIPINE HYDROCHLORIDE
Belgium
ZANIDIP
LERCANIDIPINE HYDROCHLORIDE
Denmark
ZANIDIP
LERCANIDIPINE HYDROCHLORIDE
Finland
ZANIDIP
LERCANIDIPINE HYDROCHLORIDE
Georgia
ZANIDIP
LERCANIDIPINE HYDROCHLORIDE
Greece
ZANIDIP
LERCANIDIPINE HYDROCHLORIDE
Ireland
ZANIDIP
LERCANIDIPINE HYDROCHLORIDE
Kazakhstan
ZANIDIP
LERCANIDIPINE HYDROCHLORIDE
Luxembourg
ZANIDIP
LERCANIDIPINE HYDROCHLORIDE
Norway
ZANIDIP
LERCANIDIPINE HYDROCHLORIDE
Portugal
ZANIDIP
LERCANIDIPINE HYDROCHLORIDE
Russian Federation
ZANIDIP
LERCANIDIPINE HYDROCHLORIDE
Spain
ZANIDIP
LERCANIDIPINE HYDROCHLORIDE
Switzerland
ZANIDIP
LERCANIDIPINE HYDROCHLORIDE
Tunisia
ZANIDIP
LERCANIDIPINE HYDROCHLORIDE
Ukraine
ZANIDIP
LERCANIDIPINE HYDROCHLORIDE
United Kingdom
ZANIDIP
LERCANIDIPINE HYDROCHLORIDE
Uzbekistan
ZANIPRESS
LERCANIDIPINE HYDROCHLORIDE
Belgium
ZANIPRESS
LERCANIDIPINE HYDROCHLORIDE
Finland
ZANIPRESS
LERCANIDIPINE HYDROCHLORIDE
Germany
ZANIPRESS
LERCANIDIPINE HYDROCHLORIDE
Luxembourg
ZANIPRESS
LERCANIDIPINE HYDROCHLORIDE
Norway
ZANIPRESS
LERCANIDIPINE HYDROCHLORIDE
Portugal
ZANIPRESS
LERCANIDIPINE HYDROCHLORIDE
Spain
ZANIPRESS
LERCANIDIPINE HYDROCHLORIDE
Switzerland
ZANIPRESS
LERCANIDIPINE HYDROCHLORIDE
Turkey
ZANIPRIL
LERCANIDIPINE HYDROCHLORIDE
Austria
ZANIPRIL
LERCANIDIPINE HYDROCHLORIDE
Italy
ZANITEK
LERCANIDIPINE HYDROCHLORIDE
Portugal
ZENEXOR
VENLAFAXINE
Tunisia
ZENTRAMIN
MAGNESIUM
Germany
ZINC
ZINC
Tunisia
No Products Found, please try another selection.

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com
ACCEPT
GO BACK

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com
ACCEPT
GO BACK

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com
ACCEPT
GO BACK

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com
ACCEPT
GO BACK

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com
ACCEPT
GO BACK

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com
ACCEPT
GO BACK

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com
ACCEPT
GO BACK

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com
ACCEPT
GO BACK

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com
ACCEPT
GO BACK

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com
ACCEPT
GO BACK

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com
ACCEPT
GO BACK
Corrine Porry
HR Business Partner, Rare Diseases

Corinne Porry is the Human Resource Business Partner of the Rare Diseases BU and is passionate about leadership development, creating thriving work environments, and helping people and organizations reaching their full potential.


She joined Recordati Rare Diseases in 2019, as the HR Lead of the EMEA region, before evolving on the current role in April 2025.


Corinne is a seasoned HR leader with widespread experience in multinational organizations, particularly within fast-paced and innovation-driven environments. Previously to Recordati, she held key HR leadership roles at MSD Vaccines, Sanofi Pasteur-MSD JV and Electronic Arts in the Entertainment Industry, where she supported major transformations, organizational designs and talent strategies. Her leadership style is grounded in empowering people, aligning teams around a shared purpose, and building inclusive, high-performing cultures. She began her career in HR management roles across diverse sectors including Retail, Biopharmaceuticals and Technology.


She holds a degree in Business Management from Rennes University and a master in Human Resources Management from the IAE of Aix-en-Provence. She is also a certified Executive Coach (ICF).

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

OK
Annuler

This website contains information about products that may not be available in all countries or may be available under different trademarks, for different indications, or in different doses. If you are a US resident please click the button below.

Stay on Global Site
Go to US site

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

OK
Annuler

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

OK
Annuler

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

OK
Annuler

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

OK
Annuler

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

OK
Annuler

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

OK
Annuler

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

OK
Annuler

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

OK
Annuler

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

OK
Annuler

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

OK
Annuler

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

OK
Annuler

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

OK
Annuler

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

OK
Annuler

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

OK
Annuler

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

OK
Annuler

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

OK
Annuler

Şu anda bu siteden, Recordati Rare Diseases’e ait kurumsal bir web sayfasından ayrılıyorsunuz. Sağlık Profesyonelleri için bilgi.

KABUL ET
REDDET

Şu anda bu siteden, Recordati Rare Diseases’e ait kurumsal bir web sayfasından ayrılıyorsunuz. Sağlık Profesyonelleri için bilgi.

KABUL ET
REDDET

Şu anda bu siteden, Recordati Rare Diseases’e ait kurumsal bir web sayfasından ayrılıyorsunuz. Sağlık Profesyonelleri için bilgi.

KABUL ET
REDDET

Şu anda bu siteden, Recordati Rare Diseases’e ait kurumsal bir web sayfasından ayrılıyorsunuz. Sağlık Profesyonelleri için bilgi.

KABUL ET
REDDET

Şu anda bu siteden, Recordati Rare Diseases’e ait kurumsal bir web sayfasından ayrılıyorsunuz. Sağlık Profesyonelleri için bilgi.

KABUL ET
REDDET

Şu anda bu siteden, Recordati Rare Diseases’e ait kurumsal bir web sayfasından ayrılıyorsunuz. Sağlık Profesyonelleri için bilgi.

KABUL ET
REDDET

Şu anda bu siteden, Recordati Rare Diseases’e ait kurumsal bir web sayfasından ayrılıyorsunuz. Sağlık Profesyonelleri için bilgi.

KABUL ET
REDDET

Şu anda bu siteden, Recordati Rare Diseases’e ait kurumsal bir web sayfasından ayrılıyorsunuz. Sağlık Profesyonelleri için bilgi.

KABUL ET
REDDET

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

 

Está a sair deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

ACEITO
NĀO ACEITO

 

Está a sair deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

ACEITO
NĀO ACEITO

 

Está a sair deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

ACEITO
NĀO ACEITO

 

Está a sair deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

ACEITO
NĀO ACEITO

 

Está a sair deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

ACEITO
NĀO ACEITO

Você está saindo deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

ACEITO
NĀO ACEITO

 

Está a sair deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

ACEITO
NĀO ACEITO

 

Está a sair deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

ACEITO
NĀO ACEITO

Você está saindo deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

ACEITO
NĀO ACEITO

 

Está a sair deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

ACEITO
NĀO ACEITO

Você está saindo deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

ACEITO
NĀO ACEITO

 

Está a sair deste site, um site corporativo da Recordati Rare Diseases, Informação para Profissionais de Saúde.

ACEITO
NĀO ACEITO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO
Ahora estás saliendo de este sitio, una página corporativa de Recordati Rare Diseases Iberia. Información para Profesionales Sanitarios.
ACEPTO
NO ACEPTO
Ahora estás saliendo de este sitio, una página corporativa de Recordati Rare Diseases Iberia. Información para Profesionales Sanitarios.
ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Le comunicamos que la ficha ténica / prospecto que aparece en el siguiente enlace es una información pública en la web de la Agenia Española de Medicamentos y Productos Sanitarios (AMPS).
¿Acepta abrir este enlace?

ACEPTO
NO ACEPTO

Réseau des Associations Vouées aux Troubles Sanguins Rares

The NRBDO is a pan Canadian coalition of not-for-profit organizations representing people with rare blood disorders and/or people with a chronic condition who are recipients of blood or blood products or their alternatives.

Visit website

Lymphoma Canada (Lymphome Canada)

Lorsque l’on est confronté à un lymphome, on se sent vite dépassé. Nous sommes une communauté au sein de laquelle on peut parler de cette maladie qui est le cinquième cancer le plus fréquent au Canada.

Visiter le site web

Acromégalie Canada

Acromégalie Canada est un organisme à but non lucratif fondé en 2019 pour rassembler les Canadiens dont la vie a été touchée par l’acromégalie. Notre mission est de sensibiliser à l’acromégalie et au gigantisme par l’éducation tout en offrant un réseau de soutien aux patients et à leurs familles à travers le Canada.

Visiter le site web

Global Genes

Global Genes est une organisation éminente de lutte contre les maladies rares. Sa mission consiste à sensibiliser et éduquer la communauté mondiale ainsi qu’à établir des relations importantes et à fournir des ressources essentielles permettant aux défenseurs de cette cause de s’engager pour lutter contre leur maladie.

Visiter le site web

Regroupement Québécois des Maladies Orphelines

Par l’entremise de son Centre d’information et de ressources en maladies rares, la RQMO fournit des renseignements et du soutien aux professionnels de la santé, aux patients qui souffrent de maladies rares et orphelines ainsi qu’à leur famille.

Visiter le site web

Collège canadien de généticiens médicaux

Le CCMG est une organisation nationale canadienne qui aide ses membres, les gouvernements et le public en assurant la certification des personnes, en établissant des normes, en dispensant des formations, et en guidant la politique d’intérêt public.

Visiter le site web

National Urea Cycle Disorders Foundation (NUCDF, fondation nationale pour les troubles du cycle de l'urée)

La NUCDF (fondation nationale pour les troubles du cycle de l’urée) est dédiée à l’identification, le traitement et la guérison des troubles du cycle de l’urée.

Visiter le site web

Canadian Organization for Rare Disorders (CORD, organisation canadienne pour les maladies rares)

La CORD (organisation canadienne pour les maladies rares) est le réseau national canadien des organisations représentant toutes les personnes atteintes de maladies rares. La CORD s’engage en vue de promouvoir une politique et un système de santé qui répondent aux besoins des personnes atteintes de maladies rares.

Visiter le site web

The Garrod Association (l'association Garrod)

The Garrod Association (l’association Garrod) est un organisme canadien permanent à l’échelle nationale dédié à la coordination de la gestion de maladies métaboliques héréditaires.

Visiter le site web

Association canadienne de porphyrie

L’Association canadienne de porphyrie s’engage à promouvoir la santé en permettant aux personnes atteintes de porphyrie d’avoir accès à un service de conseil et à des informations pertinentes ainsi qu’à des programmes de soutien de groupe.

Visiter le site web

Vous quittez Recordatiraredisease.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

OK
Annuler

Vous quittez Recordatirarediseases.com :

Vous quittez recordatirarediseases.com, un site Web de Recordati Rare Diseases. Recordati Rare Diseases ne vérifie ni ne contrôle le contenu des sites Web externes. Les procédures de confidentialité de Recordati Rare Diseases ne s’appliquent pas aux sites Web externes et les hyperliens ne constituent pas une approbation par Recordati Rare Diseases du contenu du site Web externe.

OK
Annuler

Network of Rare Blood Disorder Organizations​

The NRBDO is a pan Canadian coalition of not-for-profit organizations representing people with rare blood disorders and/or people with a chronic condition who are recipients of blood or blood products or their alternatives.

Visit website

Lymphoma Canada

Dealing with lymphoma can be overwhelming. We are community that helps people talk about and cope with the fifth most common cancer in Canada.

Visit Website

Acromegaly Canada

Acromegaly Canada is a not-for-profit established in 2019 to bring together Canadians whose lives have been touched by acromegaly. Our mission: to raise awareness of acromegaly and gigantism through education while providing a network of support for patients and their families across Canada.

Visit Website

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com
ACCEPT
GO BACK

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com
ACCEPT
GO BACK

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com
ACCEPT
GO BACK

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com
ACCEPT
GO BACK

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com
ACCEPT
GO BACK

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com
ACCEPT
GO BACK

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com
ACCEPT
GO BACK

Leaving recordatirarediseases.com

You are now leaving recordatirarediseases.com
ACCEPT
GO BACK

Regroupement Québécois des Maladies Orphelines

Through its Center for Information and Resources on Rare Diseases, RQMO provides information and support to health professionals and to patients with rare and orphan diseases and their families.

Visit Website

Canadian College of Medical Geneticists

CCMG is a national Canadian organization that serves its members, governments and the public by certifying individuals, establishing standards, providing education, and informing public policy.

Visit Website

National Urea Cycle Disorders Foundation

The NUCDF is dedicated to the identification, treatment and cure of urea cycle disorders.

Visit website

Canadian Organization for Rare Disorders

CORD is Canada’s national network for organizations representing all those with rare disorders. CORD provides a strong common voice to advocate for health policy and a healthcare system that works for those with rare disorders.
Visit Website

The Garrod Association

The Garrod Association is a permanent Canadian body at the national level for the coordination of the management of inherited metabolic disorders.
Visit Website

Global Genes

Global Genes is a leading rare disease advocacy organization. Their mission is to build awareness, educate the global community, and provide critical connections and resources that equip advocates to become activists for their disease.
Visit Website

Canadian Association for Porphyria

The Canadian Association for Porphyria is dedicated to promoting health by providing individuals with porphyria access to related counselling, information, and group support programs.
Visit Website
Elisabeth Bergmans
Head of Legal

Elisabeth holds a master degree in corporate and commercial law from the University of Maastricht, and has 17 years experience in the legal profession. She began her career at the Benelux law firm Loyens & Loeff in Amsterdam where she specialized in Private Equity, banking & finance and insolvency & restructuring.


Feeling the need to work closer to the business, Elisabeth then held different positions as Legal Counsel in various industries, such as pension fund investment management, sustainable energy and a private equity fund. In 2015 she joined Teva Pharmaceuticals’ European headquarters in Amsterdam, covering over the years different roles with growing responsibilities; in her last remit she was General Counsel EU Commercial, responsible for the European regional legal support of innovative medicines and commercial HQ activities. In 2021, Elisabeth moved to Milan and continued her activities from there.


In September 2024 she joined Recordati as Head of Legal RRD where she is responsible for the global legal support of the Rare Diseases B.U.

Davide Paganoni
Head of Oncology Franchise

Davide is a biologist with more than 20 years of experience in the Health Care business with a broad commercial experience that ranges from rare disease to OTC.  He joined RRD in 2022, with the acquisition of EUSA, where he used to be Head of Europe and Global Marketing. Prior to EUSA Davide had more experiences as General Manager for biotech and pharma companies as Amryt and Exeltis and before he gained a strong experience in rare disease and ultra-specialistic areas covering senior commercial roles in highly recognized companies like Alexion and Astra Zeneca.

Aziza Johnson
Head of Regulatory Affairs

Aziza Johnson holds a Bachelor of Pharmacy from the London School of Pharmacy and a master’s degree in law from the University of Leicester. She is also a certified Board member, having completed the ZHAW Board of Directors program.

 

Aziza has over 27 years of experience in regulatory affairs, clinical development, and scientific strategy across global pharmaceutical companies and regulatory agencies. She has worked on numerous drug development programs, from clinical trials to market launches, with expertise in orphan drug development, regulatory compliance, and pharmacovigilance. Her career spans leadership roles in both the public and private sectors, including positions at Pfizer and the Medicines and Healthcare products Regulatory Agency (MHRA), where she honed her skills in pharmaceutical regulation and drug approval processes. She also facilitated over 25 successful acquisitions, expanded into new markets, and secured numerous regulatory approvals across the FDA, EMA, MHRA, CFDA, TGA, ANVISA, and Health Canada.

 

In 2023, Aziza joined Recordati Rare Diseases as Head of Regulatory Affairs, where she oversees global regulatory affairs for treatments targeting rare diseases. She leads efforts to secure regulatory approvals across diverse markets, ensuring patients with unmet medical needs receive timely access to innovative therapies.

Francesco Palombi
Head of Finance

Francesco Palombi is an experienced finance executive with over 25 years of global experience across pharmaceuticals, energy, and luxury goods. He holds a Master’s degree in Business Management from the University Cattolica del Sacro Cuore of Milan.

 

He began his career in 1997 at Price Waterhouse and later moved to ENI S.p.A. and Snam Rete Gas, where he managed financial audits, reporting, and external financial statements. In 2005, he joined Roche, advancing to roles including Head of Accounting & Credit Management, Head of Finance & Manufacturing Controlling, and Head of Controlling & Business Analysis.

 

In 2015, he became CFO of Roche Thailand & New Markets, managing finance across multiple countries. He later served as Global Head of Finance for Supply Chain and Product Strategy at Roche, leading financial strategy for global supply chain and product management, before assuming his current role as Global Finance Head at Recordati Rare Diseases in 2022.

Juan-Carlos Gerena
Group Supply Chain Head

Juan Carlos Gerena is a results-driven executive with over 20 years of global experience in manufacturing, supply chain, and business development across diverse industries, including FMCG, pharmaceuticals (branded and generics), and commodities. He has a proven track record of leading large-scale transformations, driving operational excellence, and managing complex end-to-end supply chains in multicultural and international environments.


Currently, as VP of Global Supply Chain at Recordati Group, Juan Carlos oversees the supply chain strategy for both Specialty Pharma and Rare Diseases divisions. Previously, he led global supply operations for renowned organizations like Sobi, Teva Pharmaceuticals, Galderma, Novartis, and Mylan, achieving major milestones such as scaling supply chains to support global expansion, integrating supply networks post-acquisition, and optimizing S&OP processes. His expertise spans strategic sourcing, logistics, CDMO management, pipeline scalability, and digital transformation.


A dynamic leader with a focus on delivering value and operational efficiency, he also played pivotal roles at Shell Oil Products Europe and Unilever, managing complex logistics optimization projects, refinery supply chains, and innovative process development initiatives.


Juan Carlos holds an MBA from the University of Houston and a Bachelor of Science in Industrial Engineering from the University of the Philippines. A skilled communicator, he is fluent in Spanish, English, Italian, and Filipino, with a working knowledge of German. His global mindset, technical expertise, and cultural adaptability make him an influential leader in driving sustainable business growth and supply chain resilience.

Gianni Paniale
Human Resources Director

Gianni holds a degree in Business Administration from Bocconi University in Milan and has built a versatile career spanning management consulting and the pharmaceutical industry.  His professional journey began in 1989 at Proudfoot, a management consulting firm specialising in productivity and quality improvements. Gianni took on progressively senior roles, eventually leading international projects across Italy, France, Germany, the UK, and the Czech Republic.


In 1997, he joined Recordati, initially responsible for the Organisation department, he later assumed leadership of human resources for the commercial organisation in Italy. In 2004, Gianni played a pivotal role in Recordati’s international expansion, leading HR efforts for acquisitions, start-ups and the consolidation of local affiliates.


In 2022, he was appointed Human Resources Director for the Rare Diseases business unit, where he oversaw HR strategies for this specialised and impactful division of the Group. His career reflects a deep commitment to fostering organisational growth and development on both a domestic and global scale.

Georg Thies
Head of Endocrinology Franchise

Georg Thies holds a diploma in Biology and has over 30 years of experience in the pharmaceutical industry.

 

His career in pharma started in 1984 with an apprenticeship at AMERSHAM BUCHLER. He later studied Biology at the GEORG-AUGUST UNIVERSITY in Göttingen and participated in the ERASMUS Program at the KING’S COLLEGE in London.

 

After 2,5 years of civil service, he continued his career at ROCHE in 1995, progressing from Key Account Manager to roles in National and International Marketing for Oncology products.

In 2002 he joined Amgen in Switzerland as International Brand Director for Oncology and Business Unit Head Oncology Switzerland. From 2008 onwards he worked as a Country Director for Sweden.

In 2011, Georg returned to Switzerland, gaining experience in Project- and New Product Planning. He was appointed European Brand Director Cardiovascular in 2012 and European Franchise Director General Medicine in 2014, overseeing Cardiology, Nephrology, Osteoporosis, and Inflammation.

In 2016, he joined SHIRE/TAKEDA, eventually becoming the Global Commercial Executive Director and later VP Global Program Lead in Endocrinology. He concluded his tenure at TAKEDA as Global Commercial Lead Gastrointestinal.

Since August 2022, Georg has been the VP RECORDATI Rare Disease Franchise Head Endocrinology.

Luca Setti
Corporate Portfolio Management Director

Luca Setti is the Corporate Portfolio Management Director at Recordati Rare Diseases, where he is responsible for the evaluation of business development opportunities, and the strategic guidance for life cycle management and pipeline projects.


Luca joined Recordati in July 2020 as Corporate Portfolio Manager, playing a pivotal role in the latest transactions performed by the company in the rare disease space, and in the management of pipeline projects.


Prior to joining Recordati, Luca worked for 10+ years in the business and corporate development departments of Alfasigma and Chiesi Farmaceutici, where he led the completion of multiple asset deals and licensing transactions.


Luca holds a Master’s Degree in Management Engineering from the Politecnico di Milano

Caring for the planet

A clean environment is essential for people’s well-being: the health of the planet and the health of people are closely connected. The air we breathe, the water we drink and the climate we live in all have an impact on our wellbeing. Focusing on people’s health and being sustainable also means prioritising environmental protection while behaving responsibly towards future generations.

 

This is why we ensure we conduct business in a socially responsible manner and in accordance with sustainable practices, national and international laws, and the demands of our stakeholders.

Caring for our communities

Contributing to the well-being of the community and dedicating part of our resources to acts of solidarity is not merely an obligation or professional duty for Recordati but a moral imperative.

 

We believe that caring for the communities in which we’re a part is essential to help them develop and grow, and to foster a sense of pride and belonging among our people.

Our Culture

The Recordati culture is built on the pillars of entrepreneurship, purpose and belonging; all have been part of our company since our beginnings in a small pharmacy in Northern Italy almost 100 years ago.

 

At the heart of our culture are our people, who are focused on always doing the right thing in the right way. We work together – across businesses, borders, time zones and national cultures – to support patients around the world in unlocking the full potential of life.

 

We give people the opportunity to develop themselves and bring their own unique ideas and perspectives to the table. Our culture is one where people can truly be the best versions of themselves, are safe to speak up and empowered to make decisions and experiment, learning as they go.

Diversity & Inclusion

Diversity is at the heart of our business and we do not tolerate any discrimination based on ethnicity, nationality, gender, sexual orientation, disability, age, political or religious belief, or any other personal characteristics.

 

We work hard to create a safe and inclusive work environment, respecting everyone’s right to physical and psychological integrity, as well as freedom of opinion and association. We know that we each of us has a role to play in the success of Recordati and each of us is rewarded for the unique contributions we make, regardless of who we are or where we come from.

Luigi Longinotti
Managing Director and General Manager EMEA

Luigi Longinotti is the Managing Director and General Manager for EMEA at Recordati Rare Diseases, where he oversees the company’s business operations across Europe, the Middle East, and North Africa. In this role, he is responsible for a broad range of functions, including Commercial, Medical Affairs, Marketing, and Market Access as well as key enabling areas such as Human Resources, Finance, Legal, Compliance to support the business’s growth and success.

 

Luigi joined Recordati in July 2014 as Corporate Portfolio Management Director for Orphan Drugs. During his tenure, he played a pivotal role in driving the expansion of the company’s rare disease portfolio, leading efforts in business development, strategic marketing, and the management of pipeline projects.

 

Prior to joining Recordati, Luigi held senior positions in business and corporate development at Chiesi Farmaceutici and Menarini Group, where he successfully led numerous high-impact asset deals and transactions.

Luigi holds a degree in Economics from the University of Florence and a Master’s in Business Innovation from the prestigious Sant’Anna School of Advanced Studies in Pisa.

Bruno Parenti
Head of LAC Region

Bruno Parenti is VP of LAC Region at Recordati Rare Diseases, leading the business in Latin America, Asia Pacific, and Russia. He started opening new markets in 2012, spearheading the expansion of operations around the globe including the direct entry in Japan, China, South Korea, Australia, Brazil, Colombia, Mexico, and Argentina. In the last 2 years, he has successfully integrated the oncology portfolio in the Region, with new launches expanding the access to these life changing therapies to more and more patients.

 

From 2019 to 2022 he has held the additional role of Head of Global Endocrinology, establishing the new HQ in Basel, building from scratch a dedicated organization and coordinating the global launch of Isturisa and the re-launch of Signifor.

 

Prior to these positions, he spent two years at Recordati Ireland overseeing international sales in the Asia-Pacific region. He served at Chiesi Farmaceutici for two years as Area Manager for the Far East. Earlier in his career, he held commercial roles at Kedrion Biopharmaceuticals where he was responsible for international markets with a focus on Latin America and the Middle East.

Mohamed Ladha
President and General Manager, North America

Mohamed Ladha is the President and General Manager at Recordati Rare Diseases where he is  responsible for the US and Canadian business. During his career,  Mohamed has held numerous leadership positions globally in hematology/oncology and specialty care to oversee business in the US, Canada, EU, China, Emerging Markets, and Japan.

 

Mohamed  joins Recordati Rare Diseases from Oncopeptides, where he was the General Manager and Executive Vice President for the US Region Business Unit. Prior to Oncopeptides, he served in a series of leadership positions of increasing responsibility at companies including Vertex Pharmaceuticals, Pfizer, Schering-Plough, Merck & Company, Hospira, ARIAD Pharmaceuticals, Takeda Oncology, and Tocagen. He started his career in basic science research focused in oncology at the Dana-Farber Cancer Institute.

 

Mohamed graduated from Hampshire College with a Bachelor of Arts degree. He also holds professional/graduate degrees from Harvard University’s Kennedy School of Government and Northwestern University’s Kellogg School of Management.

Scott Pescatore
Executive Vice President

Scott Pescatore is Vice President and Head of Global Operations at Recordati Rare Diseases.

He holds a Doctor of Pharmacy degree and completed his post-doctoral fellowship in Pharmacology and Drug Development. Dr Pescatore has spent over 20 years working internationally in the pharmaceutical industry, specializing in oncology, haematology and rare diseases.

He joined Novartis Oncology US in 2001 where he served in various medical, sales and marketing roles of increasing responsibility. In 2008, he moved to Novartis Oncology UK as Business Franchise Head for solid tumours where he also managed the New Products portfolio. In 2010 he moved to Milan to manage the Region Europe Haematology Franchise where he led the joint venture between Novartis Oncology and Incyte to launch a novel treatment for myeloproliferative disorders. In 2014 he was appointed the Oncology General Manager in Ireland and after three years returned to Milan as General Manager of the Region Europe Rare Disease Business Unit, overseeing operations in 37 markets and focusing on the endocrinology portfolio.

Prior to joining Recordati Rare Diseases in 2020, he was Vice President Oncology Business Unit for AstraZeneca Italy where he was responsible for the portfolio of oncology/haematology products including two joint ventures with MSD and Daiichi Sankyo.

You are about to leave this site and visit the recordati global website?

To continue please click the link below.

Visit Global Site